Share on StockTwits
 

Humana (NYSE:HUM) will be issuing its quarterly earnings data on Wednesday, February 5th. Humana has set its FY13 guidance at $8.65-8.75 EPS.Investors that wish to register for the company’s conference call can do so using this link.

Humana (NYSE:HUM) last released its earnings data on Wednesday, November 6th. The company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.17. The company had revenue of $10.00 billion for the quarter, compared to the consensus estimate of $10.27 billion. During the same quarter in the previous year, the company posted $2.62 earnings per share. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. On average, analysts expect Humana to post $8.75 EPS for the current fiscal year and $7.81 EPS for the next fiscal year.

Shares of Humana (NYSE:HUM) opened at 96.36 on Tuesday. Humana has a 52-week low of $65.88 and a 52-week high of $105.80. The stock has a 50-day moving average of $99.21 and a 200-day moving average of $96.01. The company has a market cap of $15.024 billion and a price-to-earnings ratio of 10.72.

A number of analysts have recently weighed in on HUM shares. Analysts at Barclays downgraded shares of Humana from an “overweight” rating to an “equal weight” rating in a research note to investors on Wednesday, January 8th. They now have a $109.00 price target on the stock. On the ratings front, analysts at Deutsche Bank downgraded shares of Humana from a “hold” rating to a “sell” rating in a research note to investors on Tuesday, January 7th. They now have a $87.00 price target on the stock, down previously from $100.76. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note to investors on Friday, December 6th. They now have a $107.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and ten have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $101.78.

Humana Inc (NYSE:HUM) is a health care company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.